NRV-NT Tablet is a combination medication containing Pregabalin 75 mg and Nortriptyline 10 mg, indicated for the management of neuropathic pain and certain types of chronic pain conditions. Pregabalin, an anticonvulsant and analgesic agent, modulates calcium channels in the central nervous system, thereby reducing the release of neurotransmitters involved in pain signaling. Nortriptyline, a tricyclic antidepressant, enhances noradrenergic and serotonergic neurotransmission, contributing to its analgesic and mood-stabilizing effects. This synergistic combination is particularly effective in alleviating symptoms associated with diabetic neuropathy, postherpetic neuralgia, fibromyalgia, and other neuropathic pain syndromes. NRV-NT Tablet should be administered as prescribed by a healthcare professional, with dosage adjustments based on therapeutic response and tolerability. Common adverse effects may include dizziness, somnolence, dry mouth, constipation, and potential cardiovascular effects such as orthostatic hypotension. Caution is advised in patients with a history of cardiac disorders, glaucoma, or renal impairment. NRV-NT is contraindicated in individuals with hypersensitivity to either component and should be used with caution in conjunction with other central nervous system depressants. Regular monitoring and adherence to prescribed dosing are essential to optimize therapeutic outcomes and minimize adverse reactions.